Myasthenic symptoms in patients with mitochondrial myopathies
✍ Scribed by Nadine Le Forestier; Pr. Romain K. Gherardi; Christian Meyrignac; Djillali Annane; Cécile Marsac; Francoise Gray; Philippe Gajdos
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 243 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
Mitochondria1 myopathies (MM) include chronic progressive external ophthalmoplegia (CPEO), Kearns-Sayre syndrome (KSS), or various encephalomyopathies.' Ptosis or weakness increasing with muscle activity suggesting myasthenia gravis (MG) have been occasionally described in patients with MM.2,4,72103' Successful anticholinesterase therapy was reported once,' decrement of the com- pound muscle action potential (CMAP) on repetitive stimulation was detected in several patients with MM,' and neuromuscular transmission defect was further suggested by single-fiber electromyography studies.*z5
We describe 3 patients with CPEO or KSS who were first thought to have MG because of ptosis, fatiguable weakness, positive neostigmine test, and electrophysiological evidence for mild to marked neuromuscular transmission block.
📜 SIMILAR VOLUMES
In recent years, several point mutations in the mitochondrial genome have been associated with human disease. PCR Polymerase Chain Reactionhestriction endonuclease based techniques provide a reliable method for screening large numbers of specimens for many of the reported mutations. Muscle tissue us